- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Conductus and Varian debut NMR probe
A new detector for NMR spectroscopy that uses high-temperaturesuperconducting technology has been introduced by Conductus ofSunnyvale, CA, and Varian Associates of Palo Alto, CA. The detector,SuperProton nmr, increases sensitivity by at least four
A new detector for NMR spectroscopy that uses high-temperature
superconducting technology has been introduced by Conductus of
Sunnyvale, CA, and Varian Associates of Palo Alto, CA. The detector,
SuperProton nmr, increases sensitivity by at least four times
over conventional probes, according to the companies. Conductus
is manufacturing the probes, which will be used with Varian's
NMR spectrometers such as the new Unity Inova line (SCAN 3/27/96).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
